Amadou khalilou SOW

Mr. Amadou khalilou SOW

Université de Bourgogne, Dijon, Bourgogne-Franche-Comté, France
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
VVVirginie Vanwymelbeke
Virginie Vanwymelbeke
CJCharles Juhel
Charles Juhel
HBHugo Bole
Hugo Bole
Amadou khalilou SOWAmadou khalilou SOW
Amadou khalilou SOW
CGCharline Guyot
Charline Guyot
MPMichel Paindavoine
Michel Paindavoine
Having a system to measure food consumption is important to establish whether individual nutritional needs are being met in order to act quickly and to minimize the risk of undernutrition. Here, we tested a smartphone-based food consumption assessment system named FoodIntech. FoodIntech, which is based on AI using deep neural networks (DNN), automatically recognizes food items and dishes and calculates food leftovers using an image-based approach, i.e., it does not require human intervention to assess food consumption. This method uses one-input and one-output images by means of the detection and synchronization of a QRcode located on the meal tray. The DNN are then used to process the images and implement food detection, segmentation and recognition. Overall, 22,544 situations analyzed from 149 dishes were used to test the reliability of this method. The reliability of the AI results, based on the central intra-class correlation coefficient values, appeared to be excellent for 39% of the dishes (n = 58 dishes) and good for 19% (n = 28). The implementation of this method is an effective way to improve the recognition of dishes and it is possible, with a sufficient number of photos, to extend the capabilities of the tool to new dishes and foods.

25 February 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JGJeanne Godon
Jeanne Godon
Amadou khalilou SOWAmadou khalilou SOW
Amadou khalilou SOW
SNSylvia Das Neves
Sylvia Das Neves
CHCoralie Humann
Coralie Humann
ABAlice Bordet
Alice Bordet
MBMathieu Blot
Mathieu Blot
Background: Doxycycline is occasionally used as step-down therapy in periprosthetic joint infections (PJI), but evidence supporting its efficacy is limited. This study aimed to estimate the effect of doxycycline on 12-month treatment failure in patients with gram-positive PJI. Methods: Adult patients with hip, knee, or shoulder PJI caused by Staphylococcus, Corynebacterium, or Cutibacterium who underwent surgery between April 2013 and April 2023 at Dijon University Hospital (France) were included. Demographic, clinical, biological, and therapeutic data were collected retrospectively. Treatment failure at 12 months was defined as clinical recurrence, new intraoperative microorganisms, surgical revision for infection, or death. The average treatment effect (ATE) of doxycycline was estimated using causal inference methods. Results: Three hundred and eighty-six patients with PJI (median age 72 years, interquartile range [IQR] = 65–80) were analyzed. Most infections involved the hip (62%) were caused by Staphylococcus aureus (64%) and/or polymicrobial (42%). Doxycycline was prescribed in 19% of patients (n = 72), for a median of 64 days (IQR = 42–84). At 12 months, treatment failure occurred in 35%, without significant difference between exposed and unexposed patients (33% vs 36%, P = .68). Overall, doxycycline was not significantly associated with treatment failure (ATE(IPTW) = −0.09; 95% CI = −0.24 to 0.05; P = .19). Subgroup analyses suggested that doxycycline reduced treatment failure by 23%–26% in S. aureus infections (P < .001), 25%–28% in patients without fever (P < .001), and 34%–35% when both conditions were present (P < .001). Conclusions: Doxycycline in combination with other antibiotics was not associated with 12-month treatment failure in PJI caused by Staphylococcus, Corynebacterium, or Cutibacterium, with potential benefits in S. aureus infection warranting confirmation in prospective studies.


25 June 2024 in Journal de Chirurgie Viscérale
Verified
Journal Article
Open access
DGDavid Gozalichvili
David Gozalichvili
IFIsabelle Fournel
Isabelle Fournel
Amadou khalilou SOWAmadou khalilou SOW
Amadou khalilou SOW
AGAdeline Guiraud
Adeline Guiraud
NMNathan Moreno-Lopez
Nathan Moreno-Lopez
POPablo Ortega-Deballon
Pablo Ortega-Deballon

11 June 2026 in BMJ Open
Verified
Journal Article
Open access
JPJose Arturo Pineda
Jose Arturo Pineda
CDCarlos Díaz
Carlos Díaz
CPCéline Plasse
Céline Plasse
JFJuan Manuel Ruiz de la Fuente
Juan Manuel Ruiz de la Fuente
CDChristian Duvillard
Christian Duvillard
JQJean-Pierre Quenot
Jean-Pierre Quenot
Introduction: Postextubation swallowing disorders (SD) are common in the intensive care unit (ICU) and are associated with severe complications, including aspiration pneumonia, a three-fold increase in reintubation risk and higher mortality. While fibreoptic endoscopic evaluation of swallowing (FEES) and videofluoroscopy are gold standards for diagnosis, they are often impractical or impossible to perform on intubated patients. The use of ultrasound offers a non-invasive, bedside alternative to evaluate the musculoskeletal structures involved in swallowing. The Echographie Identifier les troubles de Déglutition Acquis en Réanimation (EIDAR) study aims to evaluate the diagnostic performance of pre-extubation ultrasound in identifying patients at risk of SD following mechanical ventilation. Methods and analysis: This prospective, monocentric diagnostic study conducted at the Dijon University Hospital ICU will include 100 adult patients ventilated for ≥48 hours. The primary outcome is the presence of SD, defined as a Penetration-Aspiration Scale score >2 during a FEES procedure performed 3 to 24 hours postextubation and independently assessed by an otolaryngologist blinded to index test results. Pre-extubation cervical ultrasound (Index Test) will be performed within 3 hours prior to extubation and measure hyoid bone ascension (primary variable of interest), geniohyoid muscle surface area and digastric muscle cross-sectional area. The diagnostic performance of cervical ultrasonographic parameters will be assessed using their discriminative capacity via a receiver operating characteristic curve. The feasibility of the ultrasound procedure in a critical care setting will also be assessed. Ethics and dissemination: The study received a favourable opinion from the independent ethics committee CPP Ouest III and is registered with the French health authority ANSM (national agency on safety in medicine and health products). It is conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Participants or their proxies provide free and informed oral consent. Results will be submitted for publication in peer-reviewed medical journals and presented at international conferences. Trial registration numbers: RCB 2023-A00461-44 and NCT05922085